Cargando…

A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy

The Electro-Neuro-Adaptive-Regulator (ENAR) device is a hand-held electrotherapy which is applied using energetic medicine principles and aspects of acupuncture theory. The aim of this paper is to report the findings of a postmarket survey of persons who have used the ENAR device. The conditions for...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonello, Rod P., Cohen, Marc, Reece, John, Aggarwal, Arun, Rigney, Curtis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068052/
https://www.ncbi.nlm.nih.gov/pubmed/24999365
http://dx.doi.org/10.1155/2014/341256
_version_ 1782322375316996096
author Bonello, Rod P.
Cohen, Marc
Reece, John
Aggarwal, Arun
Rigney, Curtis
author_facet Bonello, Rod P.
Cohen, Marc
Reece, John
Aggarwal, Arun
Rigney, Curtis
author_sort Bonello, Rod P.
collection PubMed
description The Electro-Neuro-Adaptive-Regulator (ENAR) device is a hand-held electrotherapy which is applied using energetic medicine principles and aspects of acupuncture theory. The aim of this paper is to report the findings of a postmarket survey of persons who have used the ENAR device. The conditions for which the therapy was used and its perceived effectiveness are discussed. A web-based survey of Australian recipients of ENAR therapy was completed by 481 respondents. Most (76%) used ENAR exclusively for pain relief for musculoskeletal disorders, especially back, shoulder, and neck pain; 8% used ENAR exclusively for nonmusculoskeletal disorders; while 16% used ENAR for both. Respondents reported a mean reduction in pain of 70% (t(423) = 38.73, P < .001) and functional improvement of 62% (t(423) = 10.45, P < .001) using 11-point numerical rating scales. Following ENAR treatment, medication reduction was reported by 91% of respondents. Most respondents reported high satisfaction following ENAR therapy, with between 15 and 20% achieving complete pain relief. The self-delivery of ENAR may, in part, account for the high level of satisfaction.
format Online
Article
Text
id pubmed-4068052
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40680522014-07-06 A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy Bonello, Rod P. Cohen, Marc Reece, John Aggarwal, Arun Rigney, Curtis Evid Based Complement Alternat Med Research Article The Electro-Neuro-Adaptive-Regulator (ENAR) device is a hand-held electrotherapy which is applied using energetic medicine principles and aspects of acupuncture theory. The aim of this paper is to report the findings of a postmarket survey of persons who have used the ENAR device. The conditions for which the therapy was used and its perceived effectiveness are discussed. A web-based survey of Australian recipients of ENAR therapy was completed by 481 respondents. Most (76%) used ENAR exclusively for pain relief for musculoskeletal disorders, especially back, shoulder, and neck pain; 8% used ENAR exclusively for nonmusculoskeletal disorders; while 16% used ENAR for both. Respondents reported a mean reduction in pain of 70% (t(423) = 38.73, P < .001) and functional improvement of 62% (t(423) = 10.45, P < .001) using 11-point numerical rating scales. Following ENAR treatment, medication reduction was reported by 91% of respondents. Most respondents reported high satisfaction following ENAR therapy, with between 15 and 20% achieving complete pain relief. The self-delivery of ENAR may, in part, account for the high level of satisfaction. Hindawi Publishing Corporation 2014 2014-06-05 /pmc/articles/PMC4068052/ /pubmed/24999365 http://dx.doi.org/10.1155/2014/341256 Text en Copyright © 2014 Rod P. Bonello et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bonello, Rod P.
Cohen, Marc
Reece, John
Aggarwal, Arun
Rigney, Curtis
A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy
title A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy
title_full A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy
title_fullStr A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy
title_full_unstemmed A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy
title_short A Postmarket Surveillance Study on Electro-Neuro-Adaptive-Regulator Therapy
title_sort postmarket surveillance study on electro-neuro-adaptive-regulator therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068052/
https://www.ncbi.nlm.nih.gov/pubmed/24999365
http://dx.doi.org/10.1155/2014/341256
work_keys_str_mv AT bonellorodp apostmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy
AT cohenmarc apostmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy
AT reecejohn apostmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy
AT aggarwalarun apostmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy
AT rigneycurtis apostmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy
AT bonellorodp postmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy
AT cohenmarc postmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy
AT reecejohn postmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy
AT aggarwalarun postmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy
AT rigneycurtis postmarketsurveillancestudyonelectroneuroadaptiveregulatortherapy